To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)
NCT00398099 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-02-17
Summary
To collect clinical response data with the use of ertapenem in approved indications.
Conditions
Interventions
- DRUG
-
MK0826, ertapenem sodium / Duration of Treatment: 14 Days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2006-01-31
- Completion
- 2006-01-31
More Related Trials
-
The Immunostimulatory Effects of Gentamicin
NCT05303909 ·Status: TERMINATED ·Phase: PHASE2
-
Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)
NCT01370616 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antibiotics on Urinary Microbiome
NCT04230746 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01426191 ·Status: COMPLETED
-
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
NCT05726318 ·Status: COMPLETED ·Phase: PHASE4
-
Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics
NCT02299882 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
NCT00811980 ·Status: COMPLETED
-
Collection of Vaginal Microbiota Samples (VAGINOTYPE)
NCT06486519 ·Status: COMPLETED
-
Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin
NCT06272994 ·Status: COMPLETED ·Phase: NA
-
Vancomycin, Gentamycin in Infective Endocarditis
NCT03688659 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
NCT00167986 ·Status: COMPLETED
-
The Clinical Impact of Isolation of Two Different Bacteria in Urinary Cultures
NCT01060956 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
NCT03224299 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
NCT05645757 ·Status: COMPLETED ·Phase: PHASE1
-
Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
NCT05689229 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
NCT05696093 ·Status: RECRUITING ·Phase: PHASE3
-
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
NCT04793152 ·Status: RECRUITING ·Phase: NA
-
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
NCT06069206 ·Status: COMPLETED ·Phase: NA
-
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
NCT02685033 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers
NCT00989872 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.
NCT03680898 ·Status: UNKNOWN ·Phase: NA
-
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
NCT00427076 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
NCT00862862 ·Status: TERMINATED
-
Vaginal Infection Study 2
NCT00694928 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Daptomycin Use in Chinese ICUs
NCT03588637 ·Status: COMPLETED